Catalyst Biosciences
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Catalyst Biosciences's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 89% to $794,000. The net income raised on -$8,242,000 and profit margin reached -1038%. Total operating expenses were $30,403,000.

Profit Margin

Catalyst Biosciences, Inc. (NASDAQ:CBIO): Profit margin
2013 3.62M -46.70M -1286.99%
2014 275K -32.62M -11862.91%
2015 1.75M -14.76M -843.54%
2016 399K -16.94M -4246.87%
2017 1.01M -21.56M -2117.98%
2018 6K -30.05M -500916.67%
2019 0 -52.88M
2020 20.94M -55.54M -265.14%
2021 7.33M -87.89M -1197.79%
2022 794K -8.24M -1038.04%

CBIO Income Statement (2013 – 2022)

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Revenue
Revenue
794K7.33M20.94M06K1.01M399K1.75M275K3.62M
Cost of revenue
798K7.38M9.16M43.85M21.47M12.84M10.55M5.95M5.26M0
Gross profit
-4K-42K11.78M-43.85M-21.46M-11.82M-10.15M-4.20M-4.99M3.62M
Operating exp.
Research and development
13.03M68.88M52.97M43.85M21.47M12.84M11.55M5.95M19.49M38.84M
Selling and marketing
0000000000
Total operating expenses
30.40M87.85M69.15M57.27M33.82M22.84M20.81M15.55M29.67M50.84M
Operating income
-8.61M-87.89M-57.37M-57.27M-33.82M-21.82M-20.41M-13.80M-29.71M-47.21M
Other income (expenses), net
717K-39K1.12M2.09M1.53M261K3.47M-960K575K518K
Income before tax
-7.89M-87.93M-56.24M-55.17M-30.05M-21.56M-16.94M-14.76M-29.13M-46.69M
Income tax expense
348K-39K-699K-2.29M3.76M-173K3.08M518K3.48M7K
Net income
-8.24M-87.89M-55.54M-52.88M-30.05M-21.56M-16.94M-14.76M-32.62M-46.70M
Earnings per share
Basic EPS
-0.26-2.87-2.9-4.41-2.68-6.3-21.76-49.99-101.4-145.78
Diluted EPS
-0.26-2.87-2.9-4.41-2.68-6.3-21.76-49.99-101.4-145.78
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source